Oghma Partners LLP is pleased to announce its role as exclusive corporate finance adviser to Softbox Systems Limited in relation to the following transaction, which completed on 2nd July 2014:
Softbox Systems Ltd sells majority stake to Great Point Partners, LLC
July 2, 2014
Oghma Partners LLP Advises the Shareholders of Softbox Systems Limited on the Sale of a Majority Stake to Great Point Partners, LLC Oghma Partners LLP (“Oghma Partners”,“Oghma”) is pleased to announce its role as exclusive financial adviser to the shareholders of Softbox Systems Limited (“Softbox”) on the sale of a majority stake in the business to Great Point Partners, LLC (“GPP”), a leading US-based healthcare investment firm with approximately US$800 million of equity capital under management.
Softbox is a leading provider of temperature controlled packaging solutions for the biotechnology and pharmaceutical industries. The Company’s products play a critical role in maintaining the integrity of temperature-sensitive drugs, vaccines and active pharmaceutical ingredients during the distribution process. The company currently supplies a number of packaging solutions to more than half of the world’s 50 largest pharmaceutical producers. Softbox has a global presence, with headquarters in the United Kingdom and locations in the United States, India, Singapore, and Australia.
The investment by GPP will enable Softbox to continue its strong growth trajectory, enabling the business to expand its global geographic footprint, diversify its product offering, and continue to invest in superior customer service for its clients.
For the full press release please click here.